News Archives - Page 579 of 735

ThursdayOct 10, 2019 1:35 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Advances Innovation Research Through Agreement with Altria

The program focuses on the pursuit of reduced risk oral nicotine products that make use of Lexaria’s patented DehydraTECH drug delivery platform DehydraTECH has been studied extensively and both human/animal trials confirm its ability to enhance active ingredient absorption in digestible products The current research could contribute to the development of oral nicotine products that would usher in a new era of reduced-risk nicotine use Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) provided an extensive update on advances in its research and development program with Altria Ventures Inc., an indirect wholly owned subsidiary of…

ThursdayOct 10, 2019 12:46 pm

Dama Financial is “One to Watch”

Provides access through bank partners to secure online, safe and convenient banking services for businesses in the cash-intensive cannabis industry Founded by banking and payments industry veterans experienced in building and scaling businesses Partnered with numerous financial institutions to help cash-intensive businesses reduce financial and safety risk, and run their businesses more efficiently Deposits held at partner banks are FDIC-insured up to $250,000 per account Dama Financial, through its bank partners, provides cannabis-related businesses (CRBs) access to transparent, sustainable banking and payment solutions. Using innovative technology, data and artificial intelligence, Dama exceeds the compliance and regulatory requirements for servicing CRBs,…

ThursdayOct 10, 2019 12:15 pm

VPR Brands LP (VPRB) Shifting Focus to Rising Star of CBD

VPR Brands focuses on the cannabis and nicotine industries The company is shifting initiatives toward cannabidiol (CBD) VPR Brands focuses on premier products and distribution in order to build sales and profits CBD products in an array of forms continue to transform the marketplace, surpassing Kim Kardashian, Beyoncé, and veganism in search popularity according to Google data (http://ibn.fm/rpYXZ). CBD is on the rise as one of the most popular terms searched, as consumers are continually looking for unique, high-quality CBD products and the enterprises that manufacture and distribute them. The forecast calls for the CBD market to grow to an estimated…

ThursdayOct 10, 2019 11:41 am

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Plans Further Expansion

IONIC Brands Corp. is a west coast company which was established in 2015 as a supplier of recreational cannabis products such as cannabis oils and vaporizer products, including vape pens IONIC Brands Corp. achieved a year-over-year increase in revenue of over 377 percent, and it plans to expand into more states across the nation IONIC expects that, by early 2020, its products will be distributed through 318 stores in California and 225 stores in Oregon IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) is a cannabis holding company supplying recreational cannabis products, with headquarters in Tacoma, Washington. The company’s…

WednesdayOct 09, 2019 12:33 pm

Neutra Corp. (NTRR) Prepares to Introduce CBD-Based Pain Relief for Athletes

As consumers have become increasingly health conscious as a fitness-interested segment of society, holistic-oriented wellness products have gained a parallel footing as alternatives to prescription drugs The trend is exemplified by the recent explosion of interest in cannabis-based products that don’t have marijuana’s drug qualities but do have muscle pain and spasm relieving properties Neutra Corp is preparing to introduce a transdermal pain-relief cream based on a CBD formulation designed to benefit athletes whose workouts induce aches and pains The CBD market is expected to top $1 billion in sales by 2022, a result of the growing interest and opportunity…

WednesdayOct 09, 2019 11:50 am

Predictive Oncology Inc. (NASDAQ: POAI) Inks its Largest Single-Hospital Sale of Revolutionary STREAMWAY(R) System

POAI recently announced the sale of 10 FDA-approved, CE-marked STREAMWAY Systems STREAMWAY Systems are the first truly continuous, direct-to drain fluid-disposal solutions designed specifically for medical applications The announcement is another positive indication that POAI subsidiary Skyline Medical offers tremendous qualitative, long-term potential In a significant announcement that bodes well for the company, Predictive Oncology Inc. (NASDAQ: POAI) announced that its Skyline Medical Division, producer of the STREAMWAY(R) System, has completed the sale of 10 systems to a major New York hospital (http://ibn.fm/dXHwp). The sale exceeds POAI’s largest single-hospital sale to date, and it is anticipated that the systems collectively will handle…

WednesdayOct 09, 2019 10:40 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) DehydraTECH Featured in Human CBD Study Results Published in Clinical Journal

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, announced that final study results of a 2018 clinical study evaluating the use of its proprietary drug-delivery system have been published (http://ibn.fm/AYzRL) (http://ibn.fm/PfnAA). Published in Advances in Therapy, a peer-reviewed medical journal, the human clinical study evaluated CBD delivery and effectiveness using LXRP-patented, DehydraTECH(TM)-powered TurboCBD(TM) capsules. Key findings highlighted in the publication included the following: CBD in-plasma levels with the TurboCBD 90 mg dose were significantly higher than with the generic 90 mg dose at both 90 and 120 minutes (p < 0.05); Only the TurboCBD 90 mg…

WednesdayOct 09, 2019 9:58 am

ORHub Inc. (ORHB) Optimizes the Business of Surgery Through Proprietary Analytics Product Surgical Spotlight

ORHub, a Microsoft Silver Partner, leverages the Azure cloud to help perioperative leaders unlock the power of health care data captured in the operating room Surgical Spotlight®, a cloud-based analytics tool, helps spot trends and outliers with curated performance indicators, increasing efficiency, decreasing costs and improving patient access in the operating room The global health care analytics market is projected to reach $50 billion by 2024, with a five-year CAGR of 28.3 percent from 2019 Chief Executive Officer Dr. Robert ‘Bobby’ Lazzara is a renowned cardiac surgeon and founder of Medical News Minute ORHub Inc. (OTC: ORHB), a cloud-based health…

TuesdayOct 08, 2019 1:39 pm

Predictive Oncology Inc. (NASDAQ: POAI) Continues to Innovate to Improve Outcomes for Cancer Patients

POAI is leveraging the potential of AI and smart tumor profiling to predict tumor drug response TumorGenesis is developing innovative techniques for growing tumors in laboratory settings Helomics uses vital information from patients’ own living tumors to assist oncologists in selecting the most effective treatments Predictive Oncology Inc. (NASDAQ: POAI) is harnessing the power of artificial intelligence (AI) and rich information from patients’ own tumors to improve outcomes for cancer patients. Predictive Oncology applies its proprietary smart tumor profiling and AI platform to extensive genomic and biomarker patient datasets in order to predict tumor drug response and improve clinical outcomes…

Site Search

Company Search

Category: News